Combined therapy with CTL cells and oncolytic adenovirus expressing IL-15-induced enhanced antitumor activity.
about
shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapyOncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy.Oncolytic Immunotherapy for Treatment of Cancer.Oncolytic viruses-immunotherapeutics on the rise.The synergistic antitumor effect of arsenic trioxide combined with cytotoxic T cells in pulmonary metastasis model of colon cancer.Improving immunotherapy for colorectal cancer using dendritic cells combined with anti-programmed death-ligand in vitro.
P2860
Combined therapy with CTL cells and oncolytic adenovirus expressing IL-15-induced enhanced antitumor activity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Combined therapy with CTL cell ...... d enhanced antitumor activity.
@en
type
label
Combined therapy with CTL cell ...... d enhanced antitumor activity.
@en
prefLabel
Combined therapy with CTL cell ...... d enhanced antitumor activity.
@en
P2093
P2860
P1433
P1476
Combined therapy with CTL cell ...... d enhanced antitumor activity.
@en
P2093
Huiwei Sun
Songyan Li
Tingting Jia
Wentao Liang
Xiaohui Du
Yingxin Xu
Yunshan Zhao
P2860
P2888
P304
P356
10.1007/S13277-015-3098-7
P50
P577
2015-01-28T00:00:00Z
P6179
1041692410